Molina Healthcare (MOH) to Release Quarterly Earnings on Wednesday

Molina Healthcare (NYSE:MOH) is scheduled to release its earnings data after the market closes on Wednesday, April 24th. Analysts expect Molina Healthcare to post earnings of $5.46 per share for the quarter. Molina Healthcare has set its FY24 guidance at at least $23.50 EPS and its FY 2024 guidance at 23.500- EPS.Investors interested in listening to the company’s conference call can do so using this link.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, February 7th. The company reported $4.38 earnings per share for the quarter, topping analysts’ consensus estimates of $4.31 by $0.07. The business had revenue of $9.05 billion during the quarter, compared to the consensus estimate of $8.35 billion. Molina Healthcare had a net margin of 3.20% and a return on equity of 32.34%. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter last year, the company earned $4.10 earnings per share. On average, analysts expect Molina Healthcare to post $24 EPS for the current fiscal year and $27 EPS for the next fiscal year.

Molina Healthcare Trading Down 1.5 %

MOH opened at $362.03 on Tuesday. Molina Healthcare has a 12-month low of $266.35 and a 12-month high of $423.92. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.54 and a quick ratio of 1.54. The stock has a market capitalization of $21.21 billion, a PE ratio of 19.28, a P/E/G ratio of 1.03 and a beta of 0.47. The firm’s fifty day moving average price is $394.33 and its 200 day moving average price is $371.60.

Insider Buying and Selling

In other news, CFO Mark Lowell Keim sold 15,000 shares of the business’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the completion of the transaction, the chief financial officer now owns 36,531 shares of the company’s stock, valued at $14,121,423.36. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, Director Richard M. Schapiro sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total value of $401,050.00. Following the sale, the director now directly owns 11,207 shares in the company, valued at approximately $4,494,567.35. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Mark Lowell Keim sold 15,000 shares of the business’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $386.56, for a total value of $5,798,400.00. Following the transaction, the chief financial officer now owns 36,531 shares of the company’s stock, valued at approximately $14,121,423.36. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 16,711 shares of company stock valued at $6,472,517. Insiders own 1.11% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $406.00 price target on shares of Molina Healthcare in a research report on Thursday, April 4th. Bank of America downgraded Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 target price on the stock. in a report on Thursday, March 28th. StockNews.com downgraded Molina Healthcare from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 8th. Truist Financial upped their price target on Molina Healthcare from $435.00 to $460.00 and gave the company a “buy” rating in a research report on Tuesday, February 20th. Finally, Wells Fargo & Company decreased their price objective on shares of Molina Healthcare from $440.00 to $410.00 and set an “equal weight” rating for the company in a report on Monday, April 15th. One analyst has rated the stock with a sell rating, four have issued a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, Molina Healthcare presently has an average rating of “Hold” and a consensus target price of $393.09.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.